U.S. Food and Drug Administration (FDA)
The U.S. Food and Drug Administration (FDA) serves as a critical federal agency under the Department of Health and Human Services, headquartered in Silver Spring, Maryland. Its mission is to safeguard public health by regulating food safety, pharmaceuticals, medical devices, and other health-related products.
Financial Indicators
The FDA operates on a budget allocated by the federal government, rather than generating revenue like traditional companies. For the fiscal year 2023, the budget for the FDA is approximately $6.4 billion. This funding supports the agency's wide array of regulatory activities and innovative initiatives.
Significant Events
One notable event for the FDA was the completion of its first AI-assisted scientific review pilot program. This program is part of the FDA's broader strategy to integrate technological advancements, aiming to streamline scientific reviews, reduce the time needed to market innovations, and maintain safety and efficacy standards.
The FDA has been proactive in ensuring the safety of infant nutrition. It has recommended recalls due to epidemiological links between certain infant formulas and illnesses, prompting investigations into contamination sources. A warning was issued regarding ByHeart’s Whole Pasture-Raised Goat Milk Infant Formula due to potential contamination with Clostridium botulinum.
Future Plans
Following the AI pilot's success, the FDA plans to expand AI technology usage across all centers by June 2025. This expansion aims to improve consistency, reduce human error, and enhance overall regulatory efficiency.
The FDA has proposed a Healthy Labeling Rule to establish front-of-package rating labels for saturated fat, sodium, and added sugar, with public comments open until July 15, 2025. Additionally, a 60-day aging requirement for raw milk cheeses is under scrutiny due to recent research findings.
The FDA is also working on new restrictions on synthetic dyes, promoting a shift to natural alternatives. Concerns over unpasteurized milk remain due to risks like bacterial contamination and bird flu, with incidents detected in California's raw milk samples.
Recent actions include accepting the GRAS notice from Formo and Those Vegan Cowboys, marking the final phase before issuing a no-questions letter, and participating in ongoing investigations and recall processes of potentially contaminated cheese products. Furthermore, a petition from Thai dairy farmers has called for mandatory labeling reforms on dairy products.
The FDA, in collaboration with the CDC, recommends commercially sterile liquid formula for infants under two months and those with weakened immune systems who are not breastfed.
Modified: 2026/09/07
Related news
Thai Dairy Farmers Protest Against Milk Powder Imports Amid Market Glut
Rising Demand for Raw Milk in Idaho Amidst Health Concerns
Nestlé Commits to Global Elimination of Artificial Colors by 2026
Clover Hill Dairy Recalls Cheese Due to Listeria Risk
FDA Clears Way for Animal-Free Dairy Protein Distribution in the US
RFK Jr.'s Advocacy for Raw Milk Stirs Debate in Fresno's Dairy Industry
Year-End Review by Food Ingredients First: Innovations in the Food and Beverage Industry Under Regulatory Pressure and Supply Chain Disruptions
FDA Criticizes Retailers for Failing to Withdraw Recalled ByHeart Infant Formula
Infant Formula Recall in the US Due to Botulism Contamination
H5N1 Avian Influenza Persistence in Raw Milk Cheeses Challenges Safety Standards
American Dairy Coalition Challenges FDA's New Healthy Labeling Rule
FDA Announces Completion of First AI-Assisted Scientific Review Pilot